Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

3.3K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
3.3K
Fibril-associated Collagen01:11

Fibril-associated Collagen

3.5K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early-life rotavirus infection susceptibility and later gastrointestinal cancer protection: Reverse antagonistic pleiotropy and potential vaccine benefits.

Current research in microbial sciences·2026
Same author

Does early-life respiratory syncytial virus infection induce epigenetic changes that promote asthma development?

Frontiers in allergy·2026
Same author

Granulomatosis with polyangiitis following Lyme disease.

The American journal of medicine·2026
Same author

Systematic review and meta-analysis reveal positive therapeutic effects of music in brain damage rehabilitation.

Frontiers in integrative neuroscience·2026
Same author

Clinical trials and new therapies in Sjögren's disease.

Current opinion in immunology·2026
Same author

Acute gluten-induced inflammatory response highlights CCL20 as a potential biomarker for celiac disease.

Frontiers in immunology·2026

Related Experiment Video

Updated: Mar 24, 2026

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
09:48

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

Published on: September 26, 2019

16.8K

Immunological Differences between Lymphocytic and Collagenous Colitis.

Anna Carrasco1, Maria Esteve1, Antonio Salas2

  • 1Department of Gastroenterology, Hospital Universitari Mútua Terrassa, Fundació Recerca Mútua Terrassa, Terrassa, Barcelona, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Terrassa, Barcelona, Spain.

Journal of Crohn'S & Colitis
|March 2, 2016
PubMed
Summary

Collagenous colitis (CC) and lymphocytic colitis (LC) share immune features like increased IL-10 and regulatory T cells, but distinct lymphocyte profiles confirm they are separate microscopic colitis disorders.

Keywords:
Collagenous colitisIL-10Th1/Th17double-negative T cellslymphocytic colitis

More Related Videos

Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
04:42

Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models

Published on: March 21, 2025

1.5K
Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

621

Related Experiment Videos

Last Updated: Mar 24, 2026

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E
09:48

Isolation of Lamina Propria Mononuclear Cells from Murine Colon Using Collagenase E

Published on: September 26, 2019

16.8K
Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
04:42

Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models

Published on: March 21, 2025

1.5K
Murine Model of Epicutaneously-Induced Immunomodulation
09:07

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

621

Area of Science:

  • Gastroenterology
  • Immunology
  • Colitis Research

Background:

  • Microscopic colitis (MC) encompasses lymphocytic colitis (LC) and collagenous colitis (CC).
  • Understanding the distinct mucosal immune characteristics of LC and CC is crucial for diagnosis and treatment.
  • This study investigates the similarities and differences in immune profiles between LC and CC.

Purpose of the Study:

  • To compare the mucosal immune cell populations in patients with LC and CC.
  • To identify shared and distinct immune mechanisms in these two forms of microscopic colitis.
  • To correlate immune findings with disease characteristics.

Main Methods:

  • Colonic biopsies were obtained from patients with CC, LC, and healthy controls.
  • Mucosal lymphocytes were analyzed using flow cytometry.
  • Gene and protein expression of key immune markers (e.g., IL-10, T cell subsets) were quantified via real-time PCR and ELISA.

Main Results:

  • LC patients exhibited lower CD4(+) and CD4(+)CD8(+) T cells, but higher CD8(+) and CD4(+)TCRγδ(+) T cells compared to controls and CC patients.
  • Both CC and LC showed increased percentages of regulatory T cells (Treg) and double-negative T cells, along with elevated anti-inflammatory IL-10 levels (mRNA and protein).
  • Th1 and Th17 cells were reduced in both CC and LC, despite increased gene expression of their associated cytokines.

Conclusions:

  • CC and LC share some immune regulatory and effector pathways, including elevated IL-10 and Treg cells, potentially preventing disease progression.
  • Distinct mucosal lymphocyte profiles in CC and LC suggest different etiological triggers, confirming them as independent intestinal disorders.
  • These findings highlight the complex immunological landscape of microscopic colitis and the need for tailored therapeutic approaches.